Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol for Retinopathy of Prematurity in Newborns
IRCT2015102524681N1Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of propranolol in retinopathy of prematurity (ROP) (2 arms), sponsored by Guilan University of Medical Sciences. Primary endpoint: Efficacy of propranolol on retinopathy of prematurity. Started Nov 2015; status: completed.
02
Drugs
propranolol
03
Conditions
retinopathy of prematurity (ROP)
Beyond the preview
Go deeper on IRCT2015102524681N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015102524681N1.